{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:17:56Z","timestamp":1793722676500,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-006-059-MY3"],"award-info":[{"award-number":["NSTC 113-2314-B-006-059-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-006-059-MY3"],"award-info":[{"award-number":["NSTC 113-2314-B-006-059-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s10620-025-08844-z","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T07:53:26Z","timestamp":1737186806000},"page":"1190-1200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD)"],"prefix":"10.1007","volume":"70","author":[{"given":"Shih-Chieh","family":"Chien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chih","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Cheng","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Hsueh","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Paolo O.","family":"Dillera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Wen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Sheng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3350-6548","authenticated-orcid":false,"given":"Horng-Yih","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9331-9018","authenticated-orcid":false,"given":"Pin-Nan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"8844_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8844_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 2023;77:1335\u20131347.","journal-title":"Hepatology"},{"key":"8844_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 2019;71:793\u2013801.","journal-title":"J Hepatol"},{"key":"8844_CR4","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023;79:1542\u20131556.","journal-title":"J Hepatol"},{"key":"8844_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cgh.2011.08.028","volume":"10","author":"AJ Montano-Loza","year":"2012","unstructured":"Montano-Loza AJ, Meza-Junco J, Prado CMM et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012;10:166\u2013731.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8844_CR6","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1002\/lt.25591","volume":"25","author":"PH Ooi","year":"2019","unstructured":"Ooi PH, Hager A, Mazurak VC et al. Sarcopenia in chronic liver disease: impact on outcomes. Liver Transpl 2019;25:1422\u20131438.","journal-title":"Liver Transpl"},{"key":"8844_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100963","volume":"6","author":"G Henin","year":"2024","unstructured":"Henin G, Loumaye A, Leclercq IA, Lanthier N. Myosteatosis: diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease. JHEP Rep 2024;6:100963.","journal-title":"JHEP Rep"},{"key":"8844_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","volume":"2","author":"RR Kalyani","year":"2014","unstructured":"Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol 2014;2:819\u2013829.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"8844_CR9","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-15-0533","volume":"229","author":"ME Cleasby","year":"2016","unstructured":"Cleasby ME, Jamieson PM, Atherton PJ. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol 2016;229:R67\u2013R81.","journal-title":"J Endocrinol"},{"key":"8844_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41574-023-00943-z","volume":"20","author":"CM Prado","year":"2024","unstructured":"Prado CM, Batsis JA, Donini LM, Gonzalez MC, Siervo M. Sarcopenic obesity in older adults: a clinical overview. Nat Rev Endocrinol 2024;20:261\u2013277.","journal-title":"Nat Rev Endocrinol"},{"key":"8844_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13534","author":"C Liu","year":"2023","unstructured":"Liu C, Wong PY, Chung YL et al. Deciphering the \u201cobesity paradox\u201d in the elderly: a systematic review and meta-analysis of sarcopenic obesity. Obes Rev. 2023. https:\/\/doi.org\/10.1111\/obr.13534.","journal-title":"Obes Rev"},{"key":"8844_CR12","first-page":"4","volume":"39","author":"KC Ueng","year":"2023","unstructured":"Ueng KC, Chiang CE, Chao TH et al. 2023 guidelines of the Taiwan society of cardiology on the diagnosis and management of chronic coronary syndrome. Acta Cardiol Sin 2023;39:4\u201396.","journal-title":"Acta Cardiol Sin"},{"key":"8844_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijcard.2012.03.017","volume":"157","author":"KL Chien","year":"2012","unstructured":"Chien KL, Hsu HC, Su TC et al. Constructing a point-based prediction model for the risk of coronary artery disease in a Chinese community: a report from a cohort study in Taiwan. Int J Cardiol 2012;157:263\u2013268.","journal-title":"Int J Cardiol"},{"key":"8844_CR14","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/ajcn\/33.11.2372","volume":"33","author":"JJ Cunningham","year":"1980","unstructured":"Cunningham JJ. A reanalysis of the factors influencing basal metabolic rate in normal adults. Am J Clin Nutr 1980;33:2372\u20132374.","journal-title":"Am J Clin Nutr"},{"key":"8844_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000521241","volume":"15","author":"M Donini Lorenzo","year":"2022","unstructured":"Donini Lorenzo M, Busetto L, Bischoff Stephan C et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts 2022;15:321\u2013335.","journal-title":"Obes Facts"},{"key":"8844_CR16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","volume":"50","author":"I Janssen","year":"2002","unstructured":"Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002;50:889\u2013896.","journal-title":"J Am Geriatr Soc"},{"key":"8844_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/oby.21694","volume":"25","author":"Y-C Hwang","year":"2017","unstructured":"Hwang Y-C, Cho I-J, Jeong I-K, Ahn KJ, Chung HY. Differential association between sarcopenia and metabolic phenotype in Korean young and older adults with and without obesity. Obesity 2017;25:244\u2013251.","journal-title":"Obesity"},{"key":"8844_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.ijo.802197","volume":"27","author":"CJ Chang","year":"2003","unstructured":"Chang CJ, Wu CH, Chang CS et al. Low body mass index but high percent body fat in Taiwanese subjects: implications of obesity cutoffs. Int J Obes Relat Metab Disord 2003;27:253\u2013259.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"8844_CR19","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","volume":"33","author":"MS LeBoff","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL et al. The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 2022;33:2049\u20132102.","journal-title":"Osteoporos Int"},{"key":"8844_CR20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313\u20131321.","journal-title":"Hepatology"},{"key":"8844_CR21","first-page":"e1082","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;139:e1082\u2013e1143.","journal-title":"Circulation"},{"key":"8844_CR22","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff Jr","year":"2014","unstructured":"Goff DC Jr, Lloyd-Jones DM, Bennett G et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:S49\u2013S73.","journal-title":"Circulation"},{"key":"8844_CR23","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/jgh.16261","volume":"38","author":"E Han","year":"2023","unstructured":"Han E, Chun HS, Lee Y-H et al. MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: a nationwide study. J Gastroenterol Hepatol 2023;38:1598\u20131609.","journal-title":"J Gastroenterol Hepatol"},{"key":"8844_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","volume":"66","author":"BK Koo","year":"2017","unstructured":"Koo BK, Kim D, Joo SK et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol 2017;66:123\u2013131.","journal-title":"J Hepatol"},{"key":"8844_CR25","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.clnu.2019.04.023","volume":"39","author":"D Gan","year":"2020","unstructured":"Gan D, Wang L, Jia M et al. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Clin Nutr 2020;39:1124\u20131130.","journal-title":"Clin Nutr"},{"key":"8844_CR26","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/hep.28376","volume":"63","author":"YH Lee","year":"2016","unstructured":"Lee YH, Kim SU, Song K et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008\u20132011). Hepatology 2016;63:776\u2013786.","journal-title":"Hepatology"},{"key":"8844_CR27","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1016\/j.cgh.2023.02.013","volume":"21","author":"M Harring","year":"2023","unstructured":"Harring M, Golabi P, Paik JM et al. Sarcopenia among patients with nonalcoholic fatty liver disease (NAFLD) is associated with advanced fibrosis. Clin Gastroenterol Hepatol 2023;21:2876-2888.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8844_CR28","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.23312","volume":"51","author":"VW Wong","year":"2010","unstructured":"Wong VW, Vergniol J, Wong GL et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010;51:454\u2013462.","journal-title":"Hepatology"},{"key":"8844_CR29","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/j.1365-2036.2011.04668.x","volume":"33","author":"S Petta","year":"2011","unstructured":"Petta S, Di Marco V, Camm\u00e0 C, Butera G, Cabibi D, Crax\u00ec A. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment Pharmacol Ther 2011;33:1350\u20131360.","journal-title":"Aliment Pharmacol Ther"},{"key":"8844_CR30","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1136\/gutjnl-2018-317334","volume":"68","author":"VW-S Wong","year":"2019","unstructured":"Wong VW-S, Irles M, Wong GL-H et al. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut 2019;68:2057\u20132064.","journal-title":"Gut"},{"key":"8844_CR31","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","volume":"65","author":"S Dasarathy","year":"2016","unstructured":"Dasarathy S, Merli M. Sarcopenia from mechanism to diagnosis and treatment in liver disease. J Hepatol 2016;65:1232\u20131244.","journal-title":"J Hepatol"},{"key":"8844_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116539","volume":"164","author":"A Al Saedi","year":"2022","unstructured":"Al Saedi A, Debruin DA, Hayes A, Hamrick M. Lipid metabolism in sarcopenia. Bone 2022;164:116539.","journal-title":"Bone"},{"key":"8844_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1213\/ANE.0b013e3181eac1c9","volume":"111","author":"PS Garc\u00eda","year":"2010","unstructured":"Garc\u00eda PS, Cabbabe A, Kambadur R, Nicholas G, Csete M. Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting. Anesth Analg 2010;111:707\u2013709.","journal-title":"Anesth Analg"},{"key":"8844_CR34","doi-asserted-by":"publisher","first-page":"18162","DOI":"10.1073\/pnas.1317049110","volume":"110","author":"J Qiu","year":"2013","unstructured":"Qiu J, Thapaliya S, Runkana A et al. Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-\u03baB-mediated mechanism. Proc Natl Acad Sci USA 2013;110:18162\u201318167.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8844_CR35","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/hep.26716","volume":"59","author":"HC Hong","year":"2014","unstructured":"Hong HC, Hwang SY, Choi HY et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology 2014;59:1772\u20131778.","journal-title":"Hepatology"},{"key":"8844_CR36","doi-asserted-by":"publisher","first-page":"736","DOI":"10.2337\/dc08-1781","volume":"32","author":"JI Barzilay","year":"2009","unstructured":"Barzilay JI, Cotsonis GA, Walston J et al. Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged \u226570 years. Diabetes Care 2009;32:736\u2013738.","journal-title":"Diabetes Care"},{"key":"8844_CR37","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2337\/dc09-2310","volume":"33","author":"TN Kim","year":"2010","unstructured":"Kim TN, Park MS, Yang SJ et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes. Diabetes Care 2010;33:1497\u20131499.","journal-title":"Diabetes Care"},{"key":"8844_CR38","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/liv.15856","volume":"44","author":"R Song","year":"2024","unstructured":"Song R, Li Z, Zhang Y, Tan J, Chen Z. Comparison of NAFLD, MAFLD and MASLD characteristics and mortality outcomes in United States adults. Liver Int 2024;44:1051\u20131060.","journal-title":"Liver Int"},{"key":"8844_CR39","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/apt.15660","volume":"51","author":"JB Henson","year":"2020","unstructured":"Henson JB, Simon TG, Kaplan A, Osganian S, Masia R, Corey KE. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2020;51:728\u2013736.","journal-title":"Aliment Pharmacol Ther"},{"key":"8844_CR40","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","volume":"19","author":"H Lee","year":"2021","unstructured":"Lee H, Lee Y-H, Kim SU, Kim HC. Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study. Clin Gastroenterol Hepatol 2021;19:2138-2147.e10.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8844_CR41","first-page":"1","volume":"2017","author":"GA Kim","year":"2017","unstructured":"Kim GA, Lee HC, Choe J et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol 2017;2017:1.","journal-title":"J Hepatol"},{"key":"8844_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100171","volume":"2","author":"P Golabi","year":"2020","unstructured":"Golabi P, Gerber L, Paik JM, Deshpande R, de Avila L, Younossi ZM. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. JHEP Rep 2020;2:100171.","journal-title":"JHEP Rep"}],"updated-by":[{"DOI":"10.1007\/s10620-026-10220-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000}}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-08844-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08844-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:01:30Z","timestamp":1787986890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-08844-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["8844"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-08844-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10620-026-10220-4","URL":"https:\/\/doi.org\/10.1007\/s10620-026-10220-4","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of NCKUH (IRB, number: A-BR-11-043). All the analysis were conducted in accordance with the institutional guidelines of National Cheng Kung University hospital, Taiwan.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the participants in this article were well informed with available informed consents.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}